GlassScriptPhysician profile
Michael A Zittle
NPI 1639176449
$4,302.65
in general payments reported to CMS, 2019-2025
17 companies · $52.61 in 2025
The $52.61 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $231 · 2021: $769 · 2022: $1,777 · 2023: $1,008 · 2024: $348 · 2025: $52.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,408.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,171.29 | 2020-2024 | Wegovy |
| Abbvie INC. | $845.92 | 2021-2023 | Vraylar, Ubrelvy, Qulipta |
| Astrazeneca Pharmaceuticals LP | $468.94 | 2019-2023 | Farxiga |
| Glaxosmithkline, LLC. | $244.12 | 2023-2024 | Arexvy |
| Lilly USA, LLC | $202.50 | 2022-2025 | Mounjaro, Zepbound |
| Alkermes, INC. | $195.15 | 2022 | |
| Abbott Laboratories | $189.26 | 2022-2023 | Freestyle Libre 3 |
| Phathom Pharmaceuticals, INC. | $157.23 | 2024 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $154.46 | 2022-2023 | |
| Biohaven Pharmaceuticals, INC. | $122.60 | 2021 | |
| Allergan, INC. | $114.53 | 2019-2020 | |
| Neurelis, INC. | $99.20 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $73.69 | 2021 | |
| Amgen INC. | $71.94 | 2023 | Evenity |
| Biohaven Pharmaceutical Holding Company LTD. | $70.03 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $63.93 | 2023 | |
| Genzyme Corporation | $57.86 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Zittle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.